Guardant Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	982.02	739.02	563.95	449.54	373.65
Revenue Growth (YoY)	32.88%	31.04%	25.45%	20.31%	30.31%
Cost of Revenue	349.01	289.8	227.05	156.33	122.91
Gross Profit	633.01	449.22	336.9	293.21	250.74
Selling, General & Admin	705.12	544.05	450.92	463.78	398.52
Research & Development	364.19	347.75	367.19	373.81	263.22
Operating Expenses	1,069	891.8	818.11	837.59	661.74
Operating Income	-436.3	-442.58	-481.22	-544.38	-411
Interest Expense	-3.9	-2.58	-2.58	-2.58	-2.58
Interest & Investment Income	34.1	53.69	35.37	6.07	3.93
Other Non Operating Income (Expenses)	8.09	1.8	2.52	-99.51	0.18
EBT Excluding Unusual Items	-398.01	-389.68	-445.91	-640.4	-409.47
Gain (Loss) on Sale of Investments	-18.58	-44.4	50.66	-13.05	-
Legal Settlements	-	-	-83.4	-	-
Other Unusual Items	-0.95	-1.01	-0.11	-	25
Pretax Income	-417.54	-435.09	-478.76	-653.45	-384.47
Income Tax Expense	-1.26	1.28	0.69	1.14	0.3
Earnings From Continuing Operations	-416.28	-436.37	-479.45	-654.59	-384.77
Minority Interest in Earnings	-	-	-	-	-20.9
Net Income	-416.28	-436.37	-479.45	-654.59	-405.67
Net Income to Common	-416.28	-436.37	-479.45	-654.59	-405.67
Shares Outstanding (Basic)	125	123	112	102	101
Shares Outstanding (Diluted)	125	123	112	102	101
Shares Change (YoY)	2.14%	9.61%	9.60%	0.85%	3.91%
EPS (Basic)	-3.32	-3.56	-4.28	-6.41	-4.00
EPS (Diluted)	-3.32	-3.56	-4.28	-6.41	-4.00
Free Cash Flow	-233.07	-274.94	-345.46	-386.92	-284.05
Free Cash Flow Per Share	-1.86	-2.24	-3.08	-3.79	-2.80
Gross Margin	64.46%	60.79%	59.74%	65.22%	67.11%
Operating Margin	-44.43%	-59.89%	-85.33%	-121.10%	-110.00%
Profit Margin	-42.39%	-59.05%	-85.02%	-145.61%	-108.57%
Free Cash Flow Margin	-23.73%	-37.20%	-61.26%	-86.07%	-76.02%
EBITDA	-396.56	-400.2	-438.33	-508.42	-388.73
EBITDA Margin	-40.38%	-54.15%	-77.73%	-113.10%	-104.04%
D&A For EBITDA	39.74	42.39	42.88	35.96	22.27
EBIT	-436.3	-442.58	-481.22	-544.38	-411
EBIT Margin	-44.43%	-59.89%	-85.33%	-121.10%	-110.00%
Revenue as Reported	-	-	-	449.54	373.65
Advertising Expenses	-	-	-	-	2.4

Updated Feb 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q